Our sarcoma program brings together nationally-recognized healthcare professionals with extensive clinical knowledge and surgical expertise. Our multidisciplinary team offers personalized treatment plans based on the type and stage of disease, each patient's genetics, life circumstances and other factors unique to the individual.
At the Seattle Cancer Care Alliance and UW Medicine, we lead the largest multidisciplinary sarcoma clinics in the Pacific Northwest. Our team-based approach brings orthopedists, radiation oncologists, pathologists and medical oncologists together to focus on the unique needs of each patient. Because of the size of our program, we have the expertise and experience to treat a variety of extremely rare and difficult to treat sarcomas. Our clinical trial program allows us to offer innovative treatment options than are not available elsewhere, which is especially important for those with less common sarcoma subtypes.
In addition to managing bone and soft-tissue sarcomas via novel, molecularly targeted therapies, Fred Hutchinson Cancer Research Center and UW Medicine are working to expand their sarcoma research collaboration to include the development of local clinical trials, involvement in national clinical trials, teaching and mentoring hematology-oncology fellows, and community-outreach activities.
Fred Hutch researchers are also discovering news ways to treat and detect Kaposi sarcoma and other infection-related cancers. Their focus is on identifying infectious diseases that cause cancer and developing new ways to prevent and cure these diseases.
Dr. Pollack is an expert on sarcomas, cancers of the bone and soft tissues. The SCCA is consistently one of the highest enrolling sites for national sarcoma clinical trials, including trials focused on patients with especially rare sarcoma subtypes. As the focus of his research, Dr. Pollack is developing new ways to enhance a sarcoma patient’s immune response against their cancer, and to thereby improve patient outcomes.